Solara Active Pharma Sciences (BOM:541540) Total Stockholders Equity : ₹10,942 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Total Stockholders Equity?

Solara Active Pharma Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹10,942 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Solara Active Pharma Sciences's Book Value per Share for the quarter that ended in Mar. 2025 was ₹227.72. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Solara Active Pharma Sciences's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.73.

Solara Active Pharma Sciences Total Stockholders Equity Historical Data

The historical data trend for Solara Active Pharma Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Total Stockholders Equity Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

15,885.30

15,248.70

15,002.10

9,339.10

10,942.40

Solara Active Pharma Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															9,339.10	-	10,860.20	-	10,942.40

Solara Active Pharma Sciences (BOM:541540) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Solara Active Pharma Sciences's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10942.4	-	0)	/	48.053
	=	227.72

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Solara Active Pharma Sciences's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6644.5	+	1316.3)	/	10942.4
	=	0.73

Solara Active Pharma Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:541540) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

SOLARAPP1:India 890202:India SOLARA:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines